key: cord-0927436-bhwthrau authors: Khan, Saman; Morabet,; Khan, Roohul Abad; Bindajam, Ahmad; Alqadhi, Saeed; Alsubih, Majed; Khan, Nadeem Ahmad title: Where we missed? Middle East respiratory syndrome (MERS-CoV) epidemiology in Saudi Arabia; 2012–2019 date: 2020-08-03 journal: Sci Total Environ DOI: 10.1016/j.scitotenv.2020.141369 sha: 8f85a95dc6b80879ec31b2a071a8680376c7481a doc_id: 927436 cord_uid: bhwthrau Abstract MERS-CoV first case was reported on 23rd November 2012 in Saudi Arabia, Since, then MERS has remained on World Health Organization (WHO) Blueprint list and declared pandemic. This study was conducted on MERS lab confirmed cases reported to Ministry of Health, Saudi Arabia and WHO for year 2012–2019. The epidemiology was investigated based on infection rate, death rate, case fatality rate, Gender, Age group, and Medical conditions (Comorbid and Symptomatic). The overall median age of infected male was 58 years and of female was 45 years. While average mortality age in male was 60 years and of female was 65 years which is greater than the global average of 50 years. The results also report that specially after age of 40 years in both men and women, chances of infection are more while comorbidities increase the infection rate. The men are more susceptible to infection than women. In case of asymptomatic distribution trend was vice versa with 69.4% women and 30.6% in men. Second, most infected age group was reduced by 20 years in case of men with 47.37% infection for age group of 20–39 years. This was also observed in age-group of 20–39 years for no comorbid cases (men (50%) & women (79%)). This explains MERS-CoV prevalence in Saudi Arabia, as young and healthy population were infected, and acted as carrier and on coming in contact with vulnerable population (Elderly, chronic and comorbid) transferred the infection. Hence, MERS-CoV outbreak kept on happening from time to time over past years. This finding might very well explain the exponential spread of Novel CoV-19 globally, as initial control measures required older people to stay indoors while younger generation brought infection from outside. Further studies are required for epidemiology analysis based on clusters, travel history and specific disease related mortality. MERS-CoV was first reported in 2012, following death of a patient at hospital in Jeddah, Kingdom of Saudi Arabia. (Poissy et al., 2014; Mohd et al., 2016; Wang et al., 2016; Eifan et al., 2017; Bawazir et al., 2018; Azhar et al., 2019) This incident acted as epicentre spreading first in neighbouring countries then globally. (Alqahtani et al., 2017) , alike Ebola or swine flu it became an alarming threat to global health security. The Middle East J o u r n a l P r e -p r o o f to human (Terada et al., 2017) subsequently by camels and goats to human in Arabian Peninsula. (Reusken et al., 2010) Its, human to human transmission especially among healthcare workers and within household contacts or by community transmission is also observed. (Al-Tawfiq et al., 2018; Elkholy et al., 2019) Between September 2012 to 30 April 2019, a total of 2428 laboratory-confirmed case and 839 associated deaths due to MERS-CoV infection were reported globally. (World Health Organization, 2019) . Most of published studies have assessed the epidemiological status of MERS-CoV infection in terms of transmission, among health care workers, healthy adult and also included gender-based prevalence. However, literature on MERS distribution based on Medical conditions is still lacking. Some studies have reported comorbidity and symptomatic distribution However, they have yet not analysed based on age and gender. Hence, objective of this study is to investigate MERS epidemiology distribution in Kingdom of Saudi Arabia based on various parameters including medical conditions. Also, to identify any parameter that has been overlooked and has led to passive action against its control globally. Our study focused MERS-CoV epidemiology based on number of cases and related deaths from 2012 to 2019 in Kingdom of Saudi Arabia. The data was obtained from global epidemiological electronic database viz. Descriptive analysis was carried out for all Laboratory confirmed-CoV cases reported to WHO for Kingdom Most of the MERS cases have medical conditions like some have comorbidity, symptomatic but rare are asymptomatic. Based on analysis 70.6% of cases were comorbid, while 21.9% cases were no comorbid and 7.5 Male Female J o u r n a l P r e -p r o o f 10 % cases are unknown. In cases of symptoms, 90.6% were symptomatic and 6.7% were asymptomatic and 2.7% were unknown. The epidemiology distribution based on comorbidity is presented in Fig. 5 was 55 years and 49.5 years respectively. The median symptomatic and asymptomatic age in female was 54.5 years and 45 years respectively. The details of symptomatic and asymptomatic cases are presented in Table 2 . J o u r n a l P r e -p r o o f The MERS-CoV epidemiology was studied in this study for Kingdom of Saudi Arabia for year 2012-2019. The recognized age group of 40-59 years as highest infected group in terms of Infection rate, death rate and fatality rate. This trend was also reflected in comorbid and symptomatic cases where highest infection was for age group 40-59 years and above. This group of age also lies in coherence with WHO identifying group range of 50-59 years with highest susceptibility of acquiring primary infection. Nevertheless, most unique finding of this study was that in all aspect of distribution men were prevailing in infection than women, however, in case of asymptomatic distribution the trend was vice versa with 69.4% women and 30.6% in men. Also, the age group reduction of 20 years was observed in men 20-39 (47.37%) while it remained same for women 40-59 (51.56%) as compared to symptomatic cases. Even though the number of asymptomatic cases is low. Additionally, in nocomorbid cases also the most infected group was 20-39 years of age with men reporting 50% and women reporting 70%. This major finding was overlooked owing to the fact that asymptomatic cases comprise only 6.71 % while no comorbid cases were upto 21%. These two categories comprise of lower percentage especially asymptomatic category, primarily due to non-testing of infected person owing to no sign of infection. However, the low percentage doesn't mean that infection was not prevalent, these cases were detected on tracing contact history and thereby testing the identified contact, hence statistics obtained does not depicts real time scenario, as there was no mass testing to detect infection among masses. Thus, this criterion was not analysed in depth in majority of studies. Nevertheless, this finding has revealed one of the primary factors that was overlooked worldwide. This is a startling revelation as till now age group with older age was considered to be highest susceptible. The younger people 20-39 years of age group went out for daily activities thinking they will be safer as 50-59 years of age group is mostly infected. However, they brought the infection back with them showing no symptoms but infected the elder population. This very well explains why MERS-CoV never stopped in Saudi Arabia, as younger group of population was infected and acted as carrier. When this group of population visited vulnerable population (Elderly, chronic and comorbid) they transferred the virus causing the infection to restart. Hence the MERS-CoV incident kept on happening from time to time over past years. This finding might very well explain the exponential spread of Novel CoV-19 globally, as initial control measures required older people to stay indoors while younger generation brought the infection from outside. Also, since the strain was new the human body adaption was too slow causing widespread of the virus globally. Hence, of people who had direct or indirect contacts with animals. However, the CoV-19 transmission is yet to be established, Hence, this may be one of the factors responsible for exponential growth rate of infection rate. Nevertheless, MERS-COV was always existing in KSA, however with early detection and proper treatment available in the country it was controlled efficiently and effectively. The major challenge faced in this study is lack of details based on gender age group and medical conditions being reported from the year 2016-2019 which may have provided more in-depth knowledge of the prevalence of the epidemiology. Further studies are required for epidemiology analysis based on clusters, travel history and specific comorbidity related mortality to provide better understanding and developing mitigation policies for the prevailing pandemic worldwide. The risk factors associated with MERS-CoV patient fatality: A global survey Challenges presented by MERS corona virus, and SARS corona virus to global health MERS coronavirus outbreak: Implications for emerging viral infections A multi-faceted approach of a nursing led education in response to MERS-CoV infection Waterpipe smoking as a public health risk: Potential risk for transmission of MERS-CoV MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract Public response to MERS-CoV in the Middle East: iPhone survey in six countries The Middle East Respiratory Syndrome (MERS) MERS-CoV infection: Mind the public knowledge gap Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: Implications for animal vaccination A pandemic risk assessment of middle east respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia MERS-CoV infection among healthcare workers and risk factors for death: Retrospective analysis of all laboratoryconfirmed cases reported to WHO from 2012 to 2 Middle East respiratory syndrome coronavirus (MERS-CoV): Impact on Saudi Arabia Predictors of MERS-CoV infection: A large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases Genetic diversity of MERS-CoV spike protein gene in Saudi Arabia MERS coronavirus nsp1 participates in an efficient propagation through a specific interaction with viral RNA MERS-CoV spike protein: Targets for vaccines and therapeutics